今日の臨床サポート 今日の臨床サポート
関連論文:
img  2:  The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population.
 
著者: Tetsuya Yamamoto, Aiko Iwase, Makoto Araie, Yasuyuki Suzuki, Haruki Abe, Shiroaki Shirato, Yasuaki Kuwayama, Hiromu K Mishima, Hiroyuki Shimizu, Goji Tomita, Yoichi Inoue, Yoshiaki Kitazawa, Tajimi Study Group, Japan Glaucoma Society
雑誌名: Ophthalmology. 2005 Oct;112(10):1661-9. doi: 10.1016/j.ophtha.2005.05.012.
Abstract/Text PURPOSE: To determine the prevalence of primary angle-closure glaucoma (PACG), secondary glaucoma (SG), and all glaucoma in a Japanese population as a part of the Tajimi Study.
DESIGN: Population-based epidemiological survey.
PARTICIPANTS: A random sample of residents 40 years or older from Tajimi, Japan.
INTERVENTION: Each subject underwent a screening program comprising an interview and an ophthalmic examination, including Goldmann applanation tonometry, slit-lamp examination, a van Herick test, fundus photography, and a screening visual field (VF) test using frequency-doubling technology. If glaucoma was suspected, the subject was referred for a definitive examination that included slit-lamp examination, gonioscopy, intraocular pressure measurement, a VF test, and optic disc and fundus examination. A diagnosis of PACG or SG was made based on slit-lamp examination, gonioscopy, optic disc appearance, and perimetric results.
MAIN OUTCOME MEASURES: Prevalences of PACG, SG, and all cases of glaucoma.
RESULTS: Of 3870 eligible people, 3021 (78.1%) participated in the study. Estimated prevalences of PACG and SG in those over 40 years were 0.6% (95% confidence interval [CI], 0.4%-0.9%) and 0.5% (95% CI, 0.2%-0.7%), respectively. Prevalences of all glaucoma and glaucoma/suspected glaucoma were estimated to be 5.0% (95% CI, 4.2%-5.8%) and 7.5% (95% CI, 6.5%-8.4%), respectively.
CONCLUSIONS: Prevalences were 0.6%, 0.5%, and 5.0%, respectively, for PACG, SG, and all glaucoma in subjects over 40 years from Tajimi, Japan.

PMID 16111758  Ophthalmology. 2005 Oct;112(10):1661-9. doi: 10.1016/j.ophtha.2005.05.012.
戻る

さらなるご利用にはご登録が必要です。

こちらよりご契約または優待日間無料トライアルお申込みをお願いします。

(※トライアルご登録は1名様につき、一度となります)


ご契約の場合はご招待された方だけのご優待特典があります。

以下の優待コードを入力いただくと、

契約期間が通常12ヵ月のところ、14ヵ月ご利用いただけます。

優待コード: (利用期限:まで)

ご契約はこちらから